Literature DB >> 29334773

MACF1 Overexpression by Transfecting the 21 kbp Large Plasmid PEGFP-C1A-ACF7 Promotes Osteoblast Differentiation and Bone Formation.

Yan Zhang1,2,3, Chong Yin1,2,3, Lifang Hu1,2,3, Zhihao Chen1,2,3, Fan Zhao1,2,3, Dijie Li1,2,3, Jianhua Ma1,2,3, Xiaoli Ma1,2,3, Peihong Su1,2,3, Wuxia Qiu1,2,3, Chaofei Yang1,2,3, Pai Wang1,2,3, Siyu Li1,2,3, Ge Zhang2,3, Liping Wang4, Airong Qian1,2,3, Cory J Xian4.   

Abstract

Microtubule actin crosslinking factor 1 (MACF1) is a large spectraplakin protein known to have crucial roles in regulating cytoskeletal dynamics, cell migration, growth, and differentiation. However, its role and action mechanism in bone remain unclear. The present study investigated optimal conditions for effective transfection of the large plasmid PEGFP-C1A-ACF7 (∼21 kbp) containing full-length human MACF1 cDNA, as well as the potential role of MACF1 in bone formation. To enhance MACF1 expression, the plasmid was transfected into osteogenic cells by electroporation in vitro and into mouse calvaria with nanoparticles. Then, transfection efficiency, osteogenic marker expression, calvarial thickness, and bone formation were analyzed. Notably, MACF1 overexpression triggered a drastic increase in osteogenic gene expression, alkaline phosphatase activity, and matrix mineralization in vitro. Mouse calvarial thickness, mineral apposition rate, and osteogenic marker protein expression were significantly enhanced by local transfection. In addition, MACF1 overexpression promoted β-catenin expression and signaling. In conclusion, MACF1 overexpression by transfecting the large plasmid containing full-length MACF1 cDNA promotes osteoblast differentiation and bone formation via β-catenin signaling. Current data will provide useful experimental parameters for the transfection of large plasmids and a novel strategy based on promoting bone formation for prevention and therapy of bone disorders.

Entities:  

Keywords:  MACF1; bone formation; large plasmid; osteoblast

Mesh:

Substances:

Year:  2018        PMID: 29334773     DOI: 10.1089/hum.2017.153

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  10 in total

1.  MACF1 promotes osteoblast differentiation by sequestering repressors in cytoplasm.

Authors:  Lifang Hu; Chong Yin; Dong Chen; Zixiang Wu; Shujing Liang; Yu Zhang; Zizhan Huang; Shuyu Liu; Xia Xu; Zhihao Chen; Yi Zhang; Airong Qian
Journal:  Cell Death Differ       Date:  2021-03-04       Impact factor: 12.067

2.  Deficiency of Macf1 in osterix expressing cells decreases bone formation by Bmp2/Smad/Runx2 pathway.

Authors:  Wu-Xia Qiu; Xiao-Li Ma; Xiao Lin; Fan Zhao; Di-Jie Li; Zhi-Hao Chen; Ke-Wen Zhang; Ru Zhang; Pai Wang; Yun-Yun Xiao; Zhi-Ping Miao; Kai Dang; Xiao-Yang Wu; Ai-Rong Qian
Journal:  J Cell Mol Med       Date:  2019-11-11       Impact factor: 5.310

Review 3.  Strength Through Unity: The Power of the Mega-Scaffold MACF1.

Authors:  Rebecca Cusseddu; Amélie Robert; Jean-François Côté
Journal:  Front Cell Dev Biol       Date:  2021-03-18

4.  MiR-138-5p Targets MACF1 to Aggravate Aging-related Bone Loss.

Authors:  Zhihao Chen; Ying Huai; Gaoyang Chen; Shuyu Liu; Yan Zhang; Dijie Li; Fan Zhao; Xiaofeng Chen; Wenjing Mao; Xuehao Wang; Chong Yin; Chaofei Yang; Xia Xu; Kang Ru; Xiaoni Deng; Lifang Hu; Yu Li; Songlin Peng; Ge Zhang; Xiao Lin; Airong Qian
Journal:  Int J Biol Sci       Date:  2022-07-18       Impact factor: 10.750

5.  Comprehensive ceRNA network for MACF1 regulates osteoblast proliferation.

Authors:  Shanfeng Jiang; Chong Yin; Kai Dang; Wenjuan Zhang; Ying Huai; Airong Qian
Journal:  BMC Genomics       Date:  2022-10-07       Impact factor: 4.547

Review 6.  Mammalian Plakins, Giant Cytolinkers: Versatile Biological Functions and Roles in Cancer.

Authors:  Lifang Hu; Zizhan Huang; Zixiang Wu; Arshad Ali; Airong Qian
Journal:  Int J Mol Sci       Date:  2018-03-24       Impact factor: 5.923

7.  Mesenchymal MACF1 Facilitates SMAD7 Nuclear Translocation to Drive Bone Formation.

Authors:  Fan Zhao; Xiaoli Ma; Wuxia Qiu; Pai Wang; Ru Zhang; Zhihao Chen; Peihong Su; Yan Zhang; Dijie Li; Jianhua Ma; Chaofei Yang; Lei Chen; Chong Yin; Ye Tian; Lifang Hu; Yu Li; Ge Zhang; Xiaoyang Wu; Airong Qian
Journal:  Cells       Date:  2020-03-04       Impact factor: 6.600

8.  Repair Method for Complete High Ulnar Nerve Injury Based on Nerve Magnified Regeneration.

Authors:  Wenquan Ding; Xueyuan Li; Jiadong Pan; Peixun Zhang; Shanqing Yin; Xianting Zhou; Junjie Li; Liping Wang; Xin Wang; Jianghui Dong
Journal:  Ther Clin Risk Manag       Date:  2020-03-03       Impact factor: 2.423

9.  Silencing of lncRNA AK045490 Promotes Osteoblast Differentiation and Bone Formation via β-Catenin/TCF1/Runx2 Signaling Axis.

Authors:  Dijie Li; Ye Tian; Chong Yin; Ying Huai; Yipu Zhao; Peihong Su; Xue Wang; Jiawei Pei; Kewen Zhang; Chaofei Yang; Kai Dang; Shanfeng Jiang; Zhiping Miao; Meng Li; Qiang Hao; Ge Zhang; Airong Qian
Journal:  Int J Mol Sci       Date:  2019-12-10       Impact factor: 5.923

10.  Silencing of miR-138-5p sensitizes bone anabolic action to mechanical stimuli.

Authors:  Zhihao Chen; Fan Zhao; Chao Liang; Lifang Hu; Dijie Li; Yan Zhang; Chong Yin; Lei Chen; Luyao Wang; Xiao Lin; Peihong Su; Jianhua Ma; Chaofei Yang; Ye Tian; Wenjuan Zhang; Yu Li; Songlin Peng; Weiyi Chen; Ge Zhang; Airong Qian
Journal:  Theranostics       Date:  2020-10-30       Impact factor: 11.556

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.